Skip to main content

Table 1 Baseline characteristics of all the patients

From: The association of HDL-apoCIII with coronary heart disease and the effect of statin treatment on it

Variables

Non-CHD

CHD

p

(n = 80)

(n = 120)

Male (%)

55.0

76.7

0.002

Age (years)

51.34 ± 8.35

55.52 ± 10.04

0.002

BMI (kg/m2)

26.19 ± 3.23

26.31 ± 3.50

0.697

Hypertension (%)

47.5

58.3

0.191

Diabetes (%)

11.3

19.2

0.247

TC (mmol/L)

4.71 ± 0.80

4.49 ± 0.94

0.088

TG (mmol/L)

1.62 ± 1.00

1.76 ± 0.84

0.079

HDL-c (mmol/L)

1.24 ± 0.36

1.02 ± 0.23

<0.001

LDL-c (mmol/L)

3.03 ± 0.78

2.88 ± 0.82

0.199

ApoAI (mmol/L)

1.48 ± 0.29

1.34 ± 0.24

0.001

ApoB (mmol/L)

1.07 ± 0.22

1.16 ± 0.31

0.020

Glucose(mmol/L)

5.64 ± 1.36

5.43 ± 1.56

0.327

HsCRP (mg/L)

1.75 ± 1.72

3.66 ± 3.58

<0.001

ApoCIII (mg/L)

12.68 ± 3.74

11.97 ± 4.94

0.275

HDL-apoCIII (ug/mgHDL)

21.00 ± 11.33

25.05 ± 12.98

0.024

  1. Data are expressed as mean ± standard deviation or percent (%). CHD = coronary heart disease; BMI = body mass index; TC = total cholesterol; TG = triglyceride; HDL-c = high density lipoprotein cholesterol; LDL-c = low density lipoprotein cholesterol; Apo = apolipoprotein; HsCRP = high sensitivity C-reactive protein; HDL-apoCIII = apoCIII content in HDL